Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Webber

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Clinical and Vaccine Immunology : CVI|June 8, 2012
Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urineMichael W Pride, Susanne M Huijts, Kangjian Wu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)Anna M M van Deursen, Marlies A van Houten, Chris Webber, et al.
The European Respiratory Journal|February 12, 2013
Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumoniaSusanne M Huijts, Michael W Pride, Josephine M I Vos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2024
CLOVER (CLOstridium difficile Vaccine Efficacy tRial) Study: A Phase 3, Randomized Trial Investigating the Efficacy and Safety of a Detoxified Toxin A/B Vaccine in Adults 50 Years and Older at Increased Risk of Clostridioides difficile InfectionCurtis J Donskey, Erik R Dubberke, Nicola P Klein, et al.
The New England Journal of Medicine|March 19, 2015
Polysaccharide conjugate vaccine against pneumococcal pneumonia in adultsMarc J M Bonten, Susanne M Huijts, Marieke Bolkenbaas, et al.
Science Translational Medicine|June 26, 2024
AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adultsYingyun Cai, Seme Diallo, Kim Rosenthal, et al.
The New England Journal of Medicine|February 15, 2023
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of AgeFlor M Muñoz, Lawrence D Sher, Charu Sabharwal, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Clinical and Vaccine Immunology : CVI|June 8, 2012
Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urineMichael W Pride, Susanne M Huijts, Kangjian Wu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)Anna M M van Deursen, Marlies A van Houten, Chris Webber, et al.
The European Respiratory Journal|February 12, 2013
Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumoniaSusanne M Huijts, Michael W Pride, Josephine M I Vos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2024
CLOVER (CLOstridium difficile Vaccine Efficacy tRial) Study: A Phase 3, Randomized Trial Investigating the Efficacy and Safety of a Detoxified Toxin A/B Vaccine in Adults 50 Years and Older at Increased Risk of Clostridioides difficile InfectionCurtis J Donskey, Erik R Dubberke, Nicola P Klein, et al.
The New England Journal of Medicine|March 19, 2015
Polysaccharide conjugate vaccine against pneumococcal pneumonia in adultsMarc J M Bonten, Susanne M Huijts, Marieke Bolkenbaas, et al.
Science Translational Medicine|June 26, 2024
AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adultsYingyun Cai, Seme Diallo, Kim Rosenthal, et al.
The New England Journal of Medicine|February 15, 2023
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of AgeFlor M Muñoz, Lawrence D Sher, Charu Sabharwal, et al.
Pageof 4